Literature DB >> 1929613

The role of multimodality therapy in soft-tissue sarcoma.

M F Brennan1, E S Casper, L B Harrison, M H Shiu, J Gaynor, S I Hajdu.   

Abstract

Soft-tissue sarcomas are uncommon malignancies. The development during a period of 8 years, in one institution, of a prospective data base incorporating more than 1600 patients with these tumors is described. The most common sites for occurrence are the extremities, but they can occur in any of the soft tissues of the body. Liposarcoma and leiomyosarcoma are the most common histopathologic conditions identified. Prognostic factors for both recurrence and survival include site, histopathology, size, grade, and adequacy of resection. A prospective randomized trial of the use of adjuvant radiation by the brachytherapy technique in extremity lesions has shown a decrease in local recurrence, but no impact on survival. Eligible patients not randomized to the trial show no difference in local recurrence or survival, regardless of whether they received adjuvant radiation.

Entities:  

Mesh:

Year:  1991        PMID: 1929613      PMCID: PMC1358657          DOI: 10.1097/00000658-199109000-00015

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  16 in total

1.  A clinical and pathological staging system for soft tissue sarcomas.

Authors:  W O Russell; J Cohen; F Enzinger; S I Hajdu; H Heise; R G Martin; W Meissner; W T Miller; R L Schmitz; H D Suit
Journal:  Cancer       Date:  1977-10       Impact factor: 6.860

2.  Reasonable surgery for rhabdomyosarcoma: a study of 67 cases.

Authors:  J W Kilman; H W Clatworthy; W A Newton; J L Grosfeld
Journal:  Ann Surg       Date:  1973-09       Impact factor: 12.969

3.  Local recurrence in adult soft-tissue sarcoma. A randomized trial of brachytherapy.

Authors:  M F Brennan; B Hilaris; M H Shiu; J Lane; G Magill; C Friedrich; S I Hajdu
Journal:  Arch Surg       Date:  1987-11

4.  Prognostic factors for local recurrence and survival in patients with localized extremity soft-tissue sarcoma.

Authors:  C F Collin; C Friedrich; J Godbold; S Hajdu; M F Brennan
Journal:  Semin Surg Oncol       Date:  1988

5.  Radiotherapy and adjuvant combination chemotherapy for childhood rhabdomyosarcoma.

Authors:  J S Malpas; J E Freeman; A Paxton; J W Smith; A G Stansfeld; C B Wood
Journal:  Br Med J       Date:  1976-01-31

6.  Localized, operable soft tissue sarcoma of the lower extremity.

Authors:  C Collin; S I Hadju; J Godbold; M H Shiu; B I Hilaris; M F Brennan
Journal:  Arch Surg       Date:  1986-12

7.  Localized extremity soft tissue sarcoma: an analysis of factors affecting survival.

Authors:  C Collin; J Godbold; S Hajdu; M Brennan
Journal:  J Clin Oncol       Date:  1987-04       Impact factor: 44.544

8.  Time dependent effects of adriamycin and x-ray therapy on wound healing in the rat.

Authors:  D F Devereux; H Kent; M F Brennan
Journal:  Cancer       Date:  1980-06-01       Impact factor: 6.860

9.  Wound complications in the multimodality treatment of extremity and superficial truncal sarcomas.

Authors:  J M Arbeit; B S Hilaris; M F Brennan
Journal:  J Clin Oncol       Date:  1987-03       Impact factor: 44.544

10.  Localized operable soft tissue sarcoma of the upper extremity. Presentation, management, and factors affecting local recurrence in 108 patients.

Authors:  C Collin; S I Hajdu; J Godbold; C Friedrich; M F Brennan
Journal:  Ann Surg       Date:  1987-04       Impact factor: 12.969

View more
  42 in total

Review 1.  Soft tissue sarcomas and p53 mutations.

Authors:  H Taubert; A Meye; P Würl
Journal:  Mol Med       Date:  1998-06       Impact factor: 6.354

2.  Brachytherapy enhanced the local control of soft-tissue sarcomas, but failed to enhance survival.

Authors:  R A Evans
Journal:  Ann Surg       Date:  1992-11       Impact factor: 12.969

3.  Multidisciplinary management of soft tissue sarcomas: it's time to make a team!

Authors:  Ángel Montero Luis
Journal:  Clin Transl Oncol       Date:  2010-08       Impact factor: 3.405

4.  Soft tissue sarcoma clinical practice guidelines in oncology.

Authors:  George D Demetri; Laurence H Baker; Derrick Beech; Robert Benjamin; Ephraim S Casper; Ernest U Conrad; Thomas F DeLaney; David S Ettinger; Martin J Heslin; Ray J Hutchinson; Krystyna Kiel; William G Kraybill; G Douglas Letson; James Neff; Richard J O'Donnell; I Benjamin Paz; Raphael E Pollock; R Lor Randall; Karen D Schupak; Douglas S Tyler; Margaret von Mehren; Jeffrey Wayne
Journal:  J Natl Compr Canc Netw       Date:  2005-03       Impact factor: 11.908

5.  Wound complications after resection and immediate postoperative brachytherapy in the management of soft-tissue sarcomas.

Authors:  R R Dalton; R M Lanciano; J P Hoffman; B L Eisenberg
Journal:  Ann Surg Oncol       Date:  1996-01       Impact factor: 5.344

6.  Local recurrence of disease after unplanned excisions of high-grade soft tissue sarcomas.

Authors:  Benjamin K Potter; Sheila C Adams; J David Pitcher; H Thomas Temple
Journal:  Clin Orthop Relat Res       Date:  2008-09-26       Impact factor: 4.176

7.  Morbid Obesity Increases the Risk of Postoperative Wound Complications, Infection, and Repeat Surgical Procedures Following Upper Extremity Limb Salvage Surgery for Soft Tissue Sarcoma.

Authors:  Matthew T Houdek; Anthony M Griffin; Peter C Ferguson; Jay S Wunder
Journal:  Hand (N Y)       Date:  2018-08-25

8.  Comparison of amputation with limb-sparing operations for adult soft tissue sarcoma of the extremity.

Authors:  W C Williard; S I Hajdu; E S Casper; M F Brennan
Journal:  Ann Surg       Date:  1992-03       Impact factor: 12.969

9.  Resectability and survival in retroperitoneal sarcomas.

Authors:  C P Karakousis; A F Velez; R Gerstenbluth; D L Driscoll
Journal:  Ann Surg Oncol       Date:  1996-03       Impact factor: 5.344

10.  Neoadjuvant chemoradiation therapy for soft tissue sarcomas of the extremities.

Authors:  Samuel Aguiar Junior; Fábio de Oliveira Ferreira; Benedito Mauro Rossi; Erika Maria Monteiro Santos; João Victor Salvajoli; Ademar Lopes
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.